Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

Journal of Experimental Medicine

Volumn 174, Issue 2, 1991, Pages 407-415

  Sattentau, Q J ^a   Moore, J P ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ENVELOPE; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BLOTTING, WESTERN; EPITOPES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMAN; PROTEIN CONFORMATION; RECEPTORS, HIV; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; VIRION;

EID: 0025866185     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.174.2.407     Document Type: Article

References (58)

1. Robey, E., and R. Axel. 1990. CD4: collaborator in immune recognition and HIV infection. Cell. 60:697.
2. Sattentau, Q.J., and R.A. Weiss. 1988. The CD4 antigen: physiological ligand and HIV receptor. Cell. 52:631.
3. Clark, S.J., W.A. Jeffries, A.N. Barclay, J. Gagnon, and A.F. Williams. 1987. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin related domains. Proc Natl. Acad. Set. USA. 84:1649.
4. Maddon, P.J., S.M. Molinaux, D.E. Maddon, K.A. Zimmerman, M. Godfrey, F.W. Alt, L. Chess, and R. Axel. 1987. Structure and expression of the human and mouse T4 genes. Proc Natl. Acad. Sci. USA. 84:9155.
5. Peterson, A., and B. Seed. 1988. Genetic analysis of monoclonal antibody and HIV binding sites on human lymphocyte antigen CD4. Cell. 54:65.
6. Clayton, L.K., R.E. Hussey, R. Steinbridge, H. Ramachan-dran, Y. Hussain, and EX. Reinherz. 1988. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gpl20 binding. Nature (Land.). 335:363.
7. Arthos, J., C.K. Deen, M.A. Chaikin, J.A. Fornwald, Q.J. Sattentau, P.R. Clapham, R.A. Weiss, J.S. McDougal, C. Pietropaulo, P.J. Maddon, A. Truneh, R. Axel, and R.W Sweet. 1989. Identification of the residues in human CD4 critical for the binding of HIV. Cell. 57:469.
8. Sattentau, Q.J., J. Arthos, K. Deen, N. Hanna, D. Healey, P.C.L. Beverley, R.W. Sweet, and A. Truneh. 1989. Structural analysis of the human immunodeficiency virus binding domain of CD4. J. Exp Med. 170:198.
9. Wang, J., Y. Yan, T.P.J. Garrett, J. Liu, D.W. Rodgers, R.L. Garlick, G.E. Tarr, Y. Husain, EX. Reinherz, and S.C. Harrison. 1990. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (Land.). 348:411.
10. Ryu, S.-E., P.D. Kwong, A. Truneh, T.G. Porter, J. Arthos, M. Rosenberg, X. Dai, N.-h. Xuong, R. Axel, R.W. Sweet, and W.A. Hendrickson. 1990. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (Land.). 348:419.
11. Camerini, D., and B. Seed. 1990. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell. 60:747.
12. Truneh, A., D. Buck, D.R. Cassat, R. Juszczak, S. Kassis, S.-E. Ryu, D. Healey, R. Sweet, and Q.J. Sattentau. 1991. A region of CD4 distinct from the primary binding site is involved in HIV infection and virus mediated fusion. J. Biol. Chem. 266:5942.
13. Celada, F., C. Cambiaggi, J. Maccari, S. Burastero, T. Gregory, E. Patzer, J. Porter, C. McDanal, and T. Matthews. 1990. Antibody raised against soluble CD4-rgpl20 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gpl20 binding. J. Exp Med. 172:1143.
14. Healey, D., L. Dianda, J.P. Moore, J.S. McDougal, M.J. Moore, P. Estess, D. Buck, P.D. Kwong, P.C.L. Beverley, and Q.J. Sattentau. 1990. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J. Exp Med. 172:1233.
15. Stein, B.S., S.D. Gowda, J.D. Lifson, R.C. Penhallow, K.G. Beusch, and E.G. Engleman. 1987. pH independent entry into CD4 positive T cells via virus envelope fusion to the plasma membrane. Cell. 49:659.
16. McClure, M.O., M. Marsh, and R.A. Weiss. 1988. Human immunodeficiency virus infection of CD4 bearing cells occurs by a pH independent mechanism. EMBO(Eur. Mol Biol. Organ.) J. 7:51.
17. Pauza, CD., and T.M. Price. 1988. HIV infection of T cells and monocytes proceeds via receptor mediated endocytosis. J. Cell Biol. 107:959.
18. Grewe, C, A. Beck, and H.R. Gelderblom. 1990. HIV: early virus-cell interactions. J. Acq. Immun. Def. Synd. 3:965.
19. Dalgleish, A.G., P.C.L. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss. 1987. The CD4 (T4) antigen is an essential component of the receptor for the AIDS virus. Nature (Land.). 312:763.
20. Sodroski, J., W.C. Goh, C. Rosen, K. Campbell, and W.A. Haseltine. 1986. Role of HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (Land.). 322:470.
21. Lifson, J.D., M.B. Feinberg, G.R. Reyes, L. Rabin, B. Bana-pour, B. Chakrabarti, B. Moss, F. Wong-Staal, K.S. Steimer, and E.G. Engleman. 1986. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (Land.). 323:725.
22. Ashorn, P.A., E.A. Berger, and B. Moss. 1990. Human immunodeficiency virus envelope glycoprotein/CD4 mediated fusion of nonprimate cells with human cells./. Virol 64:2149.
23. Kirsh, R., T.K. Hart, H. Ellens, J. Miller, S.A. Pettewayjr., D.M. Lambert, J. Leary, and P.J. Bugelski. 1990. Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gpl20 from HIV-1. AIDS Res. Hum. Retroviruses. 6:1215.
24. Moore, J.P., J.A. McKeating, R.A. Weiss, and Q.J. Sattentau.1990.Dissociation of gpl20 from HIV-1 virions induced by soluble CD4. Science (Wash. DC). 250:1139.
25. Moore, J.P., J.A. McKeating, W.A. Norton, and Q.J. Sattentau.1991.Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gpl20 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4. J. Virol. 65:1133.
26. Hart, T.K., R. Kirsh, H. Ellens, R.W. Sweet, D.M. Lambert, S.R. Petteway, J. Leary, and P. Bugelski. 1991. CD4-HIV-1 interactions: binding of soluble CD4 (sT4) to HIV-1 and HIV-1 infected cells induces shedding of envelope gpl20. Proc Natl. Acad. Sei. USA. 88:2189.
27. Skehel, J.J., P.M. Bayley, E.B. Brown, S.R. Martin, M.D. Waterfield, J.M. White, I.A. Wilson, and D.C. Wiley. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl. Acad. Sei. USA. 79:968.
28. White, J., and I.A. Wilson. 1987. Anti-peptide antibodies detect steps in a protein conformational change: low pH activation of the influenza virus hemagglutinin. J. Cell Biol 105:2887.
29. Allan, J.S., J. Strauss, and D. Buck. 1990. Enhancement of SIV infection with soluble receptor molecules. Science (Wash. DC). 247:1084.
30. Werner, A., G. Winowsky, and R. Kurth. 1990. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection. J. Virol 64:6252.
31. Sekigawa, I., S.M. Chamow, J.E. Groopman, and R.A. Byrn. 1990. CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type-2 infected lymphoid cells. J. Virol. 64:5194.
32. Gallaher, W.R. 1987. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell. 50:327.
33. Gonzalez-Scarano, F., M.N. Waxham, A.M. Ross, and J.A. Hoxie. 1987. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res. Hum. Retroviruses. 3:245.
34. McCune, M., L.B. Rabin, M.B. Feinberg, M. Lieberman, J.C. Kosek, G.R. Reyes, and IX. Weissman. 1988. Endoproteo-lytic cleavage of gpl60 is required for the activation of human immunodeficiency virus. Cell. 53:55.
35. Bosch, MX., PX. Earl, K. Fargnoli, S. Picciafuoco, F. Giom-bini, F. Wong-Staal, and G. Franchini. 1989. Identification of the fusion peptide of primate immunodeficiency viruses. Science (Wash. DC). 244:694.
36. Freed, E.O., D.J. Myers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type I envelope glycoprotein gp41. Proc Natl. Acad. Sei. USA. 87:4650.
37. Skinner, M.A., R. Ting, A.J. Langlois, K.J. Weinhold, H.K. Lyerly, K. Javaherian, and T.J. Matthews. 1988. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res. Hum. Retroviruses. 4:187.
38. Linsley, P.S., J.A. Ledbetter, E. Kinney Thomas, andS.-L. Hu.1988.Effects of anti-gpl20 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. J. Virol. 62:3695.
39. Moore, J.P. 1990. Sample methods for monitoring HIV-1 and HIV-2 gpl20 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4. AIDS (NY). 4:297.
40. Gorny, M.K., V. Gianakakos, S. Sharpe, and S. Zolla-Pazner.1989.Generation of human monoclonal antibodies to human immunodeficiency virus. Proc Natl. Acad. Sci. USA. 86:1624.
41. Deen, K.C., J.S. McDougal, R. Inacker, G. Folena Wasserman, J. Arthos, M. Rosenberg, P.J. Maddon, R. Axel, and R. Sweet. 1988. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature (Land.). 331:82.
42. McKeating, J.A., A. McKnight, and J.P. Moore. 1991. Differential loss of envelope glycoprotein gpl20 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J. Virol. 65:852.
43. Clements, G.J., M.J. Price-Jones, P.E. Stephens, C. Sutton, T.F. Schulz, P.R. Clapham, J.A. McKeating, M.O. McClure, S. Thompson, M. Marsh, J. Kay, R.A. Weiss, and J.P. Moore. 1991. The V3 loop of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses. 7:3.
44. Pinter, A., W.J. Honnen, S.A. Tilley, C. Bona, H. Zaghouani, M.K. Gorney, and S. Zolla-Pazner. 1989. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63:2674.
45. Schawaller, M., C.E. Smith, J.J. Skehel, and D.C. Wiley. 1989. Studies with cross-linking agents on the oligomeric structure of the env glycoprotein of HIV. Virology. 172:367.
46. Doms, R.W., P.L. Earl, S. Chakrabarti, and B. Moss. 1990. Human immunodeficiency viruses types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain. J. Virol. 64:3537.
47. Javaherian, K., A.J. Langlois, C. McDanal, K.L. Ross, L.I. Ecker, C.L. Jellis, A.T. Profy, J.R. Rusche, D.P. Bolognesi, S. Putney, and T.J. Matthews. 1989. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl. Acad. Sci. USA. 86:6768.
48. Skinner, M.A., A.J. Langlois, C.B. McDanal, J.S. McDougal, D.P. Bolognesi, and T.J. Matthews. 1988. Neutralising antibodies to an immunodominant envelope sequence do not prevent gpl20 binding to CD4. J. Virol. 62:4195.
49. Heiseth, E., M. Kowalski, D. Gabuzda, U. Olshevsky, W. Haseltine, and J. Sodroski. 1990. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants./. Virol. 64:2416.
50. Freed, E., O., D.J. Myers, and R. Risser. 1991. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain.J. Virol. 65:190.
51. Hattorf, T, A. Koito, K. Takatsuki, H. Kido, and N. Kata-numa. 1989. Involvement of tryptase-related cellular proteases in human immunodeficiency virus type 1 infection. FEBS (Fed. Eur. Biochem. Soc) Lett. 248
52. Koito, A., T. Hattorf, T. Murakami, S. Matsushita, Y. Maeda, T. Yamamoto, and K. Takatsuki. 1989. A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inter-a-trypsin inhibitor. Int. Immunol. 1:613.
53. + lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. /. Biol Chem. 265:21979.
54. Stephens, P.E., G. Clements, G.T. Yarranton, and J.P. Moore. 1990. A chink in HIVs armour? Nature (Land.). 343:219.
55. Gnann, J.W., Jr., J.A. Nelson, and M.B.A. Oldstone. 1987. Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus./. Virol. 61:2639.
56. Quershi, N.M., D.H. Coy, R.F. Garry, and L.A. Henderson.1990.Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS (NY). 4:553.
57. Gallaher, W.R., J.M. Ball, R.F. Garry, M.C. Griffin, and R.C. Montelaro. 1989. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses. 5:431.
58. Allen, J.S. (technical comment), and J.P. Moore, J.A. McKeating, R.A. Weiss, P.R. Clapham, and Q.J. Sattentau. (reply)1991.Receptor mediated activation of immunodeficiency viruses in viral fusion. Science (Wash. DC). 252:1322.